Literature DB >> 18814077

Ischemic cholangiopathy.

Pierre Deltenre1, Dominique-Charles Valla.   

Abstract

Bile ducts are supplied with blood exclusively via hepatic arteries. Obstruction of large arteries is rapidly compensated for by the opening of preexisting intrahepatic or transcapsular collateral arteries, which prevents ischemic damage. Ischemic bile duct injury may occur when small hepatic arteries or the peribiliary vascular plexus are injured, or when all possible arterial blood supplies are interrupted, as is the case in transplanted liver with hepatic artery thrombosis. Most causes of bile duct ischemia are iatrogenic. Systemic diseases involving small hepatic arteries may also be implicated. Depending on the extent and velocity of the arterial obstructive process, ischemic cholangiopathy may present as acute formation of biliary casts, bile duct necrosis, or chronic disease resembling primary sclerosing cholangitis. In many patients, correction of arterial obstruction is not possible. When biliary drainage or reconstruction is not possible or has failed, liver transplantation is the only means of providing potential cure.

Entities:  

Mesh:

Year:  2008        PMID: 18814077     DOI: 10.1055/s-0028-1085092

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  18 in total

1.  The implications of the presence of an aberrant right hepatic artery in patients undergoing a pancreaticoduodenectomy.

Authors:  Asif Jah; Neville Jamieson; Emmanuel Huguet; Raaj Praseedom
Journal:  Surg Today       Date:  2009-07-29       Impact factor: 2.549

Review 2.  Biliary tract anatomy and its relationship with venous drainage.

Authors:  Chittapuram S Ramesh Babu; Malay Sharma
Journal:  J Clin Exp Hepatol       Date:  2013-05-25

Review 3.  Portal cavernoma cholangiopathy: an endoscopic ultrasound based imaging approach.

Authors:  Malay Sharma; Chittapuram S Rameshbabu
Journal:  J Clin Exp Hepatol       Date:  2013-09-26

Review 4.  MRI evaluation of bile duct injuries and other post-cholecystectomy complications.

Authors:  Shilpa Reddy; Camila Lopes Vendrami; Pardeep Mittal; Amir A Borhani; Courtney C Moreno; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2021-02-12

5.  Spectrum of biliary abnormalities in portal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHPVO)-a prospective magnetic resonance cholangiopancreaticography (MRCP) based study.

Authors:  Shumyla Jabeen; Irfan Robbani; Naseer A Choh; Obaid Ashraf; Feroze Shaheen; Tariq Gojwari; Sabeeha Gul
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

Review 6.  Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Authors:  Radha K Dhiman; Vivek A Saraswat; Dominique C Valla; Yogesh Chawla; Arunanshu Behera; Vibha Varma; Swastik Agarwal; Ajay Duseja; Pankaj Puri; Naveen Kalra; Chittapuram S Rameshbabu; Vikram Bhatia; Malay Sharma; Manoj Kumar; Subhash Gupta; Sunil Taneja; Leileshwar Kaman; Showkat A Zargar; Samiran Nundy; Shivaram P Singh; Subrat K Acharya; Jang B Dilawari
Journal:  J Clin Exp Hepatol       Date:  2014-02-25

7.  Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.

Authors:  Paolo Onori; Eugenio Gaudio; Antonio Franchitto; Gianfranco Alpini; Heather Francis
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

Review 8.  Portal cavernoma cholangiopathy - history, definition and nomenclature.

Authors:  Yogesh Chawla; Swastik Agrawal
Journal:  J Clin Exp Hepatol       Date:  2013-04-17

Review 9.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

Review 10.  Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.

Authors:  Nieun Seo; So Yeon Kim; Seung Soo Lee; Jae Ho Byun; Jin Hee Kim; Hyoung Jung Kim; Moon-Gyu Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.